checkAd
    Startseite > Aktien > Jaguar Health > Nachrichten
    Jaguar Health Aktie
    ISIN: US47010C4096 · WKN: A2PLYX · USA

    Neueste Nachrichten

    Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
    29.05.24 · Accesswire · Jaguar Health
    Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea
    28.05.24 · Accesswire · Jaguar Health
    Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product
    23.05.24 · Accesswire · Jaguar Health
    Jaguar Health, Inc. Announces Reverse Stock Split
    17.05.24 · Accesswire · Jaguar Health
    Jaguar Health Reports First Quarter 2024 Financial Results
    14.05.24 · Accesswire · Jaguar Health
    REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates
    13.05.24 · Accesswire · Jaguar Health
    Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome (SBS) in Europe
    09.05.24 · Accesswire · Jaguar Health
    Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates
    08.05.24 · Accesswire · Jaguar Health
    Crofelemer, Jaguar Health’s Prescription Drug Conditionally Approved by the FDA for Chemotherapy-Induced Diarrhea in Dogs, is the Subject of the Company’s Investigational New Animal Drug Application for the Indication of General Diarrhea in Dogs
    06.05.24 · Accesswire · Jaguar Health
    Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion About Microvillus Inclusion Disease (MVID)
    29.04.24 · Accesswire · Jaguar Health
    Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in Support of Company’s Expanding Focus on Cancer Supportive Care
    22.04.24 · Accesswire · Jaguar Health
    Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care
    18.04.24 · Accesswire · Jaguar Health